Tips for Post-Approval Change Management

The initial indications of a potential failure during a site transfer can manifest in various forms:Click to read the full article.

The pharmaceutical manufacturing facility was experiencing unexpected variations in a critical quality attribute (CQA) during the production of a highly regulated injectables product. The symptoms included:Click to read the full…

During the internal audit, several critical symptoms were identified on the manufacturing floor and in the quality control lab:Click to read the full article.

Identifying symptoms or signals on the production floor or in the lab is the first step to proactively managing post-approval changes. Symptoms can be detected through:Click to read the full…

Recognizing the early signs of data integrity risks related to post-approval changes is vital in preventing major quality issues. Common symptoms that indicate potential problems include:Click to read the full…

Identifying symptoms related to post-approval changes is critical to mitigating risks. Common indicators may include:Click to read the full article.

Effective training begins with recognizing the symptoms and signals that indicate issues with post-approval change management. Look for the following signs:Click to read the full article.

Recognizing symptoms that indicate a need for improvement in post-approval change management is critical. Common signs include:Click to read the full article.

The first indicators of a potential issue stemming from a post-approval change often surface as symptoms on the manufacturing floor or in quality control laboratories. Identifying these symptoms is crucial…

Effective monitoring begins with identifying symptoms that may signal issues related to post-approval changes. These symptoms are often the first indicators that something may be amiss in the production or…

The initial signs of a potential issue surfaced during routine batch release testing at a mid-sized biopharmaceutical manufacturer. Analysts observed that several batches of an injectable product were failing to…

During a routine batch review, PharMax's Quality Control (QC) team noted discrepancies in the formulation of a high-demand product that had recently undergone a post-approval change. Signals indicating a problem…